Psyence Biomedical Ltd. — Form 6-K Summary
Business Context and Reporting Period
Psyence Biomedical Ltd., an Ontario corporation and foreign private issuer, filed this Form 6-K for March 2024. The filing reports Nasdaq listing deficiencies disclosed on March 15, 2024, based on notices received by the Company on March 11, 2024.
Financial and Liquidity Metrics
The filing does not provide revenue, profit, cash flow, margin, debt, liquidity, or other operating financial metrics.
- Nasdaq determined that the Company’s Market Value of Listed Securities (MVLS) was below the required $50 million minimum for the preceding 30 consecutive business days.
- Nasdaq determined that the Company’s Market Value of Publicly Held Shares (MVPHS) was below the required $15 million minimum for the preceding 30 consecutive business days.
Material Changes and Listing Status
The Company received two Nasdaq deficiency notices under Nasdaq Listing Rule 5450(b)(2). The notices have no immediate effect on the listing, and the Company’s securities continue to trade on the Nasdaq Global Market.
Under Nasdaq Listing Rule 5810(c)(3)(C), the Company has until September 9, 2024, to regain compliance. For each standard, the applicable market value must close at or above the required threshold for at least 10 consecutive business days during the compliance period.
Outlook, Risks, and Unusual Items
Management stated that it intends to actively monitor MVLS and MVPHS and evaluate available options to regain compliance. The Company cautioned that there can be no assurance it will regain compliance with either standard or remain compliant with other Nasdaq listing requirements.
Key Facts for Investors to Verify
- Whether MVLS reached at least $50 million for 10 consecutive business days by September 9, 2024.
- Whether MVPHS reached at least $15 million for 10 consecutive business days by September 9, 2024.
- Any subsequent Nasdaq notices, extensions, hearings, or decisions regarding continued listing.
- Whether the Company remained compliant with other Nasdaq listing criteria.
- The filing text does not provide a clear value for revenue, cash balances, operating losses, debt, or available financing.